Ibritumomab, known as Zevalin, represents the novel form of specific radiotherapy used to manage certain forms of non-Hodgkin's lymphoma , particularly relapsed lymphomas. This is a monoclonal molecule https://www.targetmol.com/compound/ibritumomab